Primoris International

PRIMORIS INTERNATIONAL — The First Mover in Bio Innovation

Primoris International is a Korean bio innovation company. Since 1994, when our founding team began stem cell research to pioneer the next generation of aesthetic medicine, we have led the exosome skinbooster market.

Built on over 30 years of stem cell research expertise, 90+ patents worldwide, and 300+ scientific publications, Primoris stands at the forefront of exosome-based clinical solutions. In particular, we hold the achievement of publishing the world's first SCI-grade paper on umbilical cord blood stem cell exosomes. Our products have been used in more than 1.7 million clinical procedures worldwide, demonstrating the safety and efficacy trusted by medical practitioners around the globe.

At the core of our technology is our proprietary ExoOrigin platform (USC1994/ PSC1994). This platform isolates the youngest, most potent stem cell-derived exosomes while minimizing biological variability. Comprising over 1,470 active ingredients — including growth factors, proteins, lipids, and miRNA — our exosomes simultaneously support hydration, elasticity, brightening, anti-inflammation, and hair restoration in a single procedure, achieving multi-dimensional skin regeneration.

Our flagship clinical brand, P198, offers a comprehensive portfolio of exosome skinboosters. All products — including P198 ExoHealer (umbilical cord blood stem cell exosome) and P198 ExoNature (Panax Ginseng plant-derived exosome) — are manufactured under GMP standards, with third-party purity verification confirming 11 times higher exosome purity compared to competing products.

Primoris International is currently conducting a Phase 1/2a clinical trial in Australia and holds regulatory registrations including PCPC, ICID, CPNP, and MoCRA. Through partnerships spanning 50+ countries, our mission is to deliver cellular-level rejuvenation science to aesthetic medicine practitioners around the world.

The First. The Best. The Next.   contact@primoris.co.kr | www.primorisintl.com